000120569 001__ 120569
000120569 005__ 20240228145453.0
000120569 0247_ $$2doi$$a10.1016/j.ejps.2017.01.036
000120569 0247_ $$2pmid$$apmid:28153636
000120569 0247_ $$2ISSN$$a0928-0987
000120569 0247_ $$2ISSN$$a1879-0720
000120569 0247_ $$2altmetric$$aaltmetric:81074151
000120569 037__ $$aDKFZ-2017-00998
000120569 041__ $$aeng
000120569 082__ $$a610
000120569 1001_ $$aDell'Albani, Paola$$b0
000120569 245__ $$aQuercetin derivatives as potent inducers of selective cytotoxicity in glioma cells.
000120569 260__ $$aNew York, NY [u.a.]$$bElsevier$$c2017
000120569 3367_ $$2DRIVER$$aarticle
000120569 3367_ $$2DataCite$$aOutput Types/Journal article
000120569 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1510057653_26478
000120569 3367_ $$2BibTeX$$aARTICLE
000120569 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000120569 3367_ $$00$$2EndNote$$aJournal Article
000120569 520__ $$aQuercetin (Q) is a flavonoid widely distributed in the plant kingdom and well-known for its ability to exert antioxidant, prooxidant and anticarcinogenic activities in several tumor cells. Furthermore, quercetin plays an important role both in the regulation of key elements in cellular signal transduction pathways related to apoptotic cell death, and in cell cycle progression. Several studies have reported of toxic effects of Q against glioma cell lines. In this study, the effects of Q and of some Q-derivatives (acyl esters and bromo-derivatives) on U373-MG and 9L glioma cell lines survival are analyzed. The 24-hour treatment of glioma cells with several concentrations of Q (25, 50 and 100μM) did not cause any cytotoxic effects, while the administration of Q-derivatives, such as acylated and brominated quercetin, caused a sharp increase in cell death. Among all tested derivatives, 3-O-decanoylquercetin 10 manifested the strongest cytotoxic effect at a concentration as low as 25μM both in U373-MG (ca. 40% viability after 24h) and in 9L cells (ca. 20% viability after 24h). The cytotoxic effects of the Q-derivatives 3 and 10-13 were proven to be satisfactorily selective for glioma cells. When Q-derivatives were in fact administered to mouse primary astroglial or human fibroblast cell cultures, a higher cell survival rate (~90-70% and 55-45%, respectively) was observed relative to that detected in glioma cells. These results prove that selective esterification and bromination of Q increase to a great extent the toxicity of this polyphenol against glioma cells, thereby providing a possible new tool for cyto-specific glioma therapy.
000120569 536__ $$0G:(DE-HGF)POF3-311$$a311 - Signalling pathways, cell and tumor biology (POF3-311)$$cPOF3-311$$fPOF III$$x0
000120569 588__ $$aDataset connected to CrossRef, PubMed,
000120569 7001_ $$0P:(DE-He78)3f238cb47096916308d99eabbce682e9$$aDi Marco, Barbara$$b1$$udkfz
000120569 7001_ $$aGrasso, Sonia$$b2
000120569 7001_ $$aRocco, Concetta$$b3
000120569 7001_ $$aFoti, Mario C$$b4
000120569 773__ $$0PERI:(DE-600)1483522-8$$a10.1016/j.ejps.2017.01.036$$gVol. 101, p. 56 - 65$$p56 - 65$$tEuropean journal of pharmaceutical sciences$$v101$$x0928-0987$$y2017
000120569 909CO $$ooai:inrepo02.dkfz.de:120569$$pVDB
000120569 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3f238cb47096916308d99eabbce682e9$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000120569 9131_ $$0G:(DE-HGF)POF3-311$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vSignalling pathways, cell and tumor biology$$x0
000120569 9141_ $$y2017
000120569 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000120569 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000120569 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000120569 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J PHARM SCI : 2015
000120569 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000120569 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000120569 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000120569 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000120569 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000120569 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000120569 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000120569 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000120569 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000120569 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000120569 9201_ $$0I:(DE-He78)A231-20160331$$kA231$$lAG Alfonso$$x0
000120569 980__ $$ajournal
000120569 980__ $$aVDB
000120569 980__ $$aI:(DE-He78)A231-20160331
000120569 980__ $$aUNRESTRICTED